Baseline malarial and nutritional profile of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 19 10 2022
accepted: 26 05 2023
medline: 28 6 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: epublish

Résumé

Seasonal Malaria chemoprevention (SMC) is one of the large-scale life-saving malaria interventions initially recommended for the Sahel subregion, including Burkina Faso and recently extended to other parts of Africa. Initially, SMC was restricted to children 3 to 59 months old, but an extension to older children in some locations was recently recommended. Further characterization of SMC population profile beyond age criterion is necessary for understanding factors that could negatively impact the effectiveness of the intervention and to define complementary measures that could enhance its impact. Children were assessed through a cross-sectional survey during the first month of the 2020 SMC campaign (July-August 2020) as part of the SMC-NUT project in the health district of Nanoro. Parameters such as body temperature, weight, height, mid-upper arm circumference (MUAC) were assessed. In addition, blood sample was collected for malaria diagnosis by rapid diagnostic tests (RDT) and microscopy, and for haemoglobin measurement. A total of 1059 children were enrolled. RDT positivity rate (RPR) was 22.2%, while microscopy positivity rate (MPR) was 10.4%, with parasitaemia levels ranging from 40 to 70480/μL. RPR and MPR increased as patient age increased. Wasting was observed in 7.25% of children under SMC coverage while the prevalence of stunting and underweight was 48.79% and 23.38%, respectively. As the age of the children increased, an improvement in their nutritional status was observed. Finally, undernourished children had higher parasite densities than children with adequate nutritional status. In the health district of Nanoro, children who received Seasonal Malaria Chemoprevention (SMC) were mostly undernourished during the period of SMC delivery, suggesting the need for combining the SMC with synergistic interventions against malnutrition to achieve best impact.

Identifiants

pubmed: 37363896
doi: 10.1371/journal.pone.0287210
pii: PONE-D-22-26751
pmc: PMC10292698
doi:

Substances chimiques

Antimalarials 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0287210

Informations de copyright

Copyright: © 2023 Sondo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist

Références

PLoS One. 2018 Jan 11;13(1):e0190983
pubmed: 29324840
Trans R Soc Trop Med Hyg. 1991 Sep-Oct;85(5):584-9
pubmed: 1780980
JAMA. 2022 Jul 19;328(3):234
pubmed: 35852520
Int J Epidemiol. 2013 Oct;42(5):1390-8
pubmed: 23925429
Am J Trop Med Hyg. 2009 Feb;80(2):202-8
pubmed: 19190214
Pan Afr Med J. 2017 Nov 24;28:265
pubmed: 29881508
Rev Epidemiol Sante Publique. 2013 Apr;61(2):111-20
pubmed: 23489948
PLoS One. 2019 Jan 25;14(1):e0210692
pubmed: 30682069
QJM. 1997 Dec;90(12):751-7
pubmed: 9536339
Clin Infect Dis. 2018 Sep 14;67(7):1027-1034
pubmed: 29522089
BMC Med. 2018 Oct 29;16(1):186
pubmed: 30371344
Indian J Pediatr. 1985 May-Jun;52(416):285-7
pubmed: 3910578
Trials. 2021 May 24;22(1):360
pubmed: 34030705
Int J Epidemiol. 2012 Oct;41(5):1293-301
pubmed: 23045201
Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):55-63
pubmed: 15331819
Am J Trop Med Hyg. 2018 Feb;98(2):524-533
pubmed: 29260654
World Rev Nutr Diet. 2015;113:278-94
pubmed: 25906897
BMC Public Health. 2015 Nov 05;15:1099
pubmed: 26541669
J Infect Dis. 2006 Jul 1;194(1):108-14
pubmed: 16741889
Malar J. 2012 Mar 27;11:90
pubmed: 22453048
Am J Clin Nutr. 1998 Sep;68(3):734-41
pubmed: 9734755
J Trop Pediatr. 2002 Apr;48(2):78-83
pubmed: 12022433
Infect Dis Poverty. 2017 Jan 13;6(1):9
pubmed: 28081711
Pathog Glob Health. 2021 Sep;115(6):423-433
pubmed: 33944705
Am J Trop Med Hyg. 2005 Oct;73(4):698-704
pubmed: 16222012

Auteurs

Paul Sondo (P)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Toussaint Rouamba (T)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Marc Christian Tahita (MC)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Karim Derra (K)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Berenger Kabore (B)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Yssimini Nadège Guillène Tibiri (YNG)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Hyacinthe Abd-El Latif Faïçal Kabore (HALF)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

So-Vii Franck Hien (SF)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Florence Ouedraogo (F)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Adama Kazienga (A)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Hamidou Ilboudo (H)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Eli Rouamba (E)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Thiery Lefevre (T)

Institut de Recherche pour le Développement (IRD), Centre National pour la Recherche Scientifique (CNRS), Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC), Université de Montpellier, Montpellier, France.

Halidou Tinto (H)

Institut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.
Institut de Recherche pour le Développement (IRD), Centre National pour la Recherche Scientifique (CNRS), Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC), Université de Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH